期刊文献+

维持性血液透析患者发生肺动脉高压的风险因素分析 被引量:10

Risk factors of pulmonary hypertension for maintenance hemodialysis patients
原文传递
导出
摘要 目的对维持性血液透析患者(MHD)并发肺动脉高压(PH)的患病情况进行调查,寻找其中的风险因素,并通过文献复习探究其可能的机制。方法选取符合入选标准的MHD患者136例,收集患者的临床资料,包括原发疾病、透析年龄、透析间期体质量增加量等;行超声心动图检查获取心脏结构及功能指标,并同时测量患者内瘘直径及内瘘血流量,评估心瓣膜及外周血管钙化的程度;在超声检查前后2周内收集患者的血生化指标,如血红蛋白、白蛋白、hs-CRP、甲状旁腺激素等。上述患者根据肺动脉压检测情况分为肺动脉高压组(PH组)与肺动脉压正常组(nPH组)。结果 136例MHD患者并发PH的发生率为38.23%;原发疾病为糖尿病较非糖尿病发病率高(χ2=11.76,P<0.001)。PH组较nPH组患者的心腔增大、心肌肥厚、收缩及舒张功能下降(均P<0.05)。PH组较nPH组患者透析间期体质量增加量上升(t=8.72,P<0.05)、血红蛋白值下降(t=-4.23,P<0.05)。Logistic多元回归分析显示透析间期体重增加/干体重百分比、血红蛋白值是MHD患者发生PH的主要风险因素,回归方程为Y=34.85+4.48X1-0.22X2。结论合并糖尿病的MHD患者PH发生率较高,透析间期体质量增加量上升、贫血可通过改变心脏结构、功能,影响PH的发生。 ObjectiveThis cross-sectional survey was intended to explore the prevalence of pulmonary hypertension (PH) in maintenance hemodialysis (MHD) patients and identify potential risk factors. Through a review of related literatures, we can explore the possible mechanism of PH in MHD patients.Methods A total of 136 MHD patients were enrolled according to the inclusion criteria. The clinical data were collected such as primary disease, dialysis age, interdialytic weight gain. Doppler echocardiographic examinations were performed in two hours to assess cardiac structures and functions. And the diameter and blood flow of fistula were measured by vascular ultrasound while gauging the calcification degree of peripheral vessels and heart valves. Also, before and after two weeks of echocardiographic examinations, such biochemical parameters as hemoglobin, albumin, hs-CRP, parathyroid hormone were measured. They were divided into PH and nPH groups.ResultsThe prevalence of PH was 38.23% in 136 MHD patients and was higher in those with diabetes than without diabetes (χ2=11.76,P〈0.001). The values of atrium and ventricle were higher, the degree of cardiac hypertrophy was greater and the cardiac systolic and diastolic function was lower in PH group than nPH group (allP〈0.05). The value of interdialytic weight gain in PH group was significantly higher than nPH group (t=8.72,P〈0.05). The value of hemoglobin in PH group was significantly lower than nPH group (t=-4.23,P〈0.05). Logistic multiple regression analysis showed interdialytic weight gain and hemoglobin were major risk factors for PH in MHD patients. And the regression equation was Y= 34.85+4.48X1-0.22X2.ConclusionThe prevalence of patients with diabetes is higher than those without diabetes, the interdialytic weight gain and anemia may cause pulmonary hypertension in MHD patientsby effecting cardiac structure and function.
出处 《中华临床医师杂志(电子版)》 CAS 2014年第12期71-77,共7页 Chinese Journal of Clinicians(Electronic Edition)
关键词 尿毒症 肾透析 高血压 肺性 危险因素 Uremia Renal dialysis Hypertension,pulmonary Risk factors
  • 相关文献

参考文献24

  • 1Yigla M, Nakhoni F, Sabag A, ctal. Pulmonary hypertension in patients with end-stage renal disease[J]. Chest, 2003, 123(5): 1577-1582.
  • 2Ramasubbu K, Deswal A, Hexdejurgen C, et al. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hernodialysis patients in the United States: prevalence and clinical significance[J]. Int J Gen IVied, 2010, 3: 279-286.
  • 3Pabst S, Hammerstingl C, Hundt F, ct al. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: result of the PEPPER-study[J]. PLoS One, 2012, 7(4): e35310.
  • 4Yigla M, Fruchtcr O, Aharonson D, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients[J]. Kidney Int, 2009, 75(9): 969-975.
  • 5邵咏红,王飞,孔耀中,赖玉琼,肖观清.血液透析患者并发肺动脉高压的相关因素分析[J].南方医科大学学报,2009,29(9):1932-1934. 被引量:10
  • 6曾宇然,王伟鸿,谭凤娇,林潭发,钟晓珊.维持性血液透析患者并发肺动脉高压影响因素分析[J].西部医学,2011,23(3):471-473. 被引量:6
  • 7Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients[J]. Nephrol Dial Transplant, 2012, 27(10): 3908-3914.
  • 8Joannidcs R, Bakkali EH, Le RY, et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis[J]. Nephrol Dial Transplant, 1997(12): 2623-2628.
  • 9Tarrass F, Benjelloun M, Medkouri G; et al. Doppler eehocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis[J]. Hemodial Int, 2006, 10(4): 356-359.
  • 10Nakhoul F, Yigla M, Gilman R, et al. The pathogesis of pulmonary hypertension in haemodialysis patients via arterin-venous access[J]. Nephrol Dial Transplant, 2005, 20(8): 1686-1692.

二级参考文献25

  • 1卢永申,阮励冰,赵显国.应用超纯透析液降低血液透析患者血浆C反应蛋白水平[J].中国血液净化,2004,3(7):406-406. 被引量:8
  • 2黎磊石,刘志红主编.中国肾脏病学[M].北京:人民军医出版社,2008,1328-1338
  • 3Yigla M, Nakhoul F, Sabag A, et al. Pulmonaryhypertension in patients with end stage renal disease[J]. Chest, 2003, 123: 1577-82.
  • 4Schiller NB. Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography [J].Cardiol Clin, 1990, 8: 277-87.
  • 5Tarrass F, Benjelloun M, Medkouri G, et al. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis[J ]. Hemodial Int, 2006, 10(4): 356-59.
  • 6Amin M, Fawzy A, Hamid MA, et al. Pulmonaryhypertension in patients with chronic renal failure: role of parathyroid gorm one and pulmonary artery calcifications[J].Chest, 2003, 124(6): 2093-7.
  • 7Yigla M, Keidar Z, Safadi I, et al. Pulmonary calcification in hemodialysis patients: Correlation with pulmonaryartery pressure values [ J ]. Kidney Int, 2004, 66: 806-10.
  • 8Yigla M, Dabbah S, Azzam ZS, et al. Background diseases in 671 patients with moderate to severe pulmonaryhypertension [J].Isr Med Assoc J, 2002, 2(9): 684-9.
  • 9Yigla M, KeidarZ, Safadi I, et al. Pulmonary calcification in hemodialysis patients: Correlation with pulmonary artery pressure values[J]. Kidney Int, 2004, 66:806-810.
  • 10Reisner SA, Azzam Z, Halmann M, et al. Septal to free wall curvature ratio: a non-invasive index of pulmonary arterial pressure[J]. J Am Soc Echocardiogr, 1994,7(4):27-35.

共引文献12

同被引文献64

  • 1杨杏,叶瑞华,周丽芹.肺动脉高压患者的病因构成与肺动脉压力因素[J].华夏医学,2020(4):67-70. 被引量:4
  • 2Navaneethan SD,Sehold JD, Huang H, et al. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephro1,2016,43 ( 1 ) :39 - 46.
  • 3Yilmaz S, Yildirim Y, Taylan M, et al. The Relationship of Fluid Overload as Assessed by Bioelectrical Impedance Analysis with Pulmonary Arterial Hypertension in Hemodialysis Patients. Med Sci Monit,2016,22(2) :488 -494.
  • 4Shen S, Sun Q. Analysis of Clinically Relevant Factors for Pulmo- nary Hypertension in Maintenance Hemodialysis Patients. Med Sci Monit ,2015,21:4050 - 4056.
  • 5He Y, Wang Y, Luo X, et al. Risk factors for pulmonary hyperten- sion in maintenance hemodialysis patients: a cross - sectional study. Int Urol Nephrol,2015,47 ( 11 ) : 1889 - 1897.
  • 6Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients [J]. Nephrol Dial Transplant,2012,27(1):3908-3914.
  • 7Etemadi J, Zolfaghari H, Firoozi R, et al. Unexplained pul- monary hypertension in peritoneal dialysis and hemodialy- sis patients[J]. Rev Port Pneumol, 2012,18 (1) : 10-14.
  • 8Wilson B, Lawrence J. Implementation of a foot assess- ment program in aregional satellite hemodialysis setting [J]. Cannt J,2013,23(1) :41-47.
  • 9孟娟,王质刚,孙倩美.血液透析患者并发肺动脉高压[J].肾脏病与透析肾移植杂志,2007,16(6):564-568. 被引量:6
  • 10孟娟,孙倩美,姜维,李忠心,黄静,李艳春.血液透析患者并发肺动脉高压的临床分析[J].中华肾脏病杂志,2009,25(2):93-96. 被引量:18

引证文献10

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部